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Abstract
Thrombospondin-1 (TSP-1) is known to be subject to three unusual carbohydrate modifications: C-mannosylation, O-
fucosylation, and O-glucosylation. We now describe a fourth: O-b-N-acetylglucosaminylation. Previously, O-b-N-
acetylglucosamine (O-b-GlcNAc) was found on a threonine in the loop between the fifth and sixth cysteines of the 20
th
epidermal growth factor (EGF)-like module of Drosophila Notch. A BLAST search based on the Drosophila Notch loop
sequence identified a number of human EGF-like modules that contain a similar sequence, including EGF-like module 1 of
TSP-1 and its homolog, TSP-2. TSP-1, which has a potentially modifiable serine in the loop, reacted in immuno-blots with the
CTD110.6 anti-O-GlcNAc antibody. Antibody reactivity was diminished by treatment of TSP-1 with b-N-acetylhexosami-
nidase. TSP-2, which lacks a potentially modifiable serine/threonine in the loop, did not react with CTD110.6. Analysis of
tandem modules of TSP-1 localized reactivity of CTD110.6 to EGF-like module 1. Top-down mass spectrometric analysis of
EGF-like module 1 demonstrated the expected modifications with glucose (+162 Da) and xylose (+132 Da) separately from
modification with N-acetyl hexosamine (+203 Da). Mass spectrometric sequence analysis localized the +203-Da modification
to Ser580 in the sequence
575CPPGYSGNGIQC
586. These results demonstrate that O-b-N-acetylglucosaminylation can occur
on secreted extracellular matrix proteins as well as on cell surface proteins.
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Introduction
Thrombospondins (TSPs) are large secreted, calcium-binding
glycoproteins. There are 5 TSPs in humans: 2 trimeric Group A
TSPs (TSP-1 and TSP-2) and 3 pentameric Group B TSPs (TSP-3,
TSP-4, TSP-5) [1]. Group A TSPs are composed of an N-terminal
module (N), an oligomerization sequence (o) that is responsible for
trimer formation, a von Willebrand Factor C module (C), three
properdin-like modules (P123), three epidermal growth factor
(EGF)-like modules (E123), a calcium-binding (Ca) wire, and a
globular lectin-like C-terminal module (G) (Figure 1) [1]. Group B
TSPs lack the C and P123 modules and contain an extra EGF-like
module [1]. TSPs are widely distributed in connective tissues,
platelets, blood vessels, and neuromuscular tissues and modulate
numerous processes through interactions with extracellular matrix
(ECM) components and cell surface receptors [2,3].
TSPs are known to be subject to three unusual carbohydrate
modifications. Group A TSPs are C-mannosylated on the
tryptophans of WXXW sequences in the properdin-like modules,
as are other proteins with similar sequences [4,5]. The properdin-
like modules also contain a CSX(S/T)C sequence that is O-
fucosylated by O-fucosyltransferase 2, which then undergoes
glucose addition, and is critical for protein maturation [4,6,7]. O-
glucosylation, as in a number of EGF-like modules containing a
CXSXPC sequence between the first and second cysteines, occurs
in the 1
st EGF-like module (E1) in TSP-2 [8] and presumably in
TSP-1 and TSP-4. The TSP-2 E1 module also has a N-
glycosylated NGT sequence between the fifth and sixth cysteines
[1]. Since extracellular EGF-like modules in Drosophila Notch have
recently been identified to contain O-linked b-N-acetylglucosa-
mine (O-b-GlcNAc) [9], we set out to identify any possible O-b-
GlcNAc modification of TSP-1 EGF-like modules. We now report
a fourth unusual modification of TSP-1: O-linked b-N-acetylglu-
cosamine (O-b-GlcNAc).
Materials and Methods
Purification of platelet TSP-1
TSP-1 was purified from releasate of thrombin-activated
platelets by heparin-agarose affinity chromatography followed by
gel exclusion chromatography as described previously [10]. The
protocol was modified to utilize fast performance liquid chroma-
tography with HiTrap Heparin and Superose12 (GE Healthcare).
Proteins were in Tris-buffered saline (TBS, 10 mM Tris, 150 mM
sodium chloride, pH 7.4) containing 0.3 or 2 mM calcium
chloride. Concentration of TSP-1 was determined by absorbance
at 280 nm [11,12].
Expression of recombinant full length TSPs or modular
constructs
The pAcGP67.coco (COCO) vector was used to produce
recombinant baculovirus with which to infect insect High Five
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directed expression of His-tagged TSP-derived constructs as
secreted proteins that could be purified facilely from conditioned
medium. This method has been shown to produce native,
glycosylated, and functional TSP modules [8,11,12,13,14,15].
Protein concentration was determined by absorbance as with
pTSP-1. The following is the sequence of the construct that
contained the E1 module of TSP-1 (underlined) and was subjected
to MS mass determination and manipulation: ADPDGCLS-
NPCFAGVKCTSPDGSWKCGACPPGYSGNGIQCTLELVP-
RGSAAGHHHHHH.
Anti-GlcNAc Immuno-blotting and SDS-PAGE
TSP protein samples were treated with SDS-PAGE loading
buffer, subjected to polyacrylamide gel electrophoresis with a 3.3%
stacking and 10% separating gel, and stained with gel code blue or
immuno-blotted as described previously [16]. CTD110.6 mouse
monoclonal antibody for O-b-GlcNAc purchased as ascites
(Abcam) and peroxidase-conjugated goat anti-mouse IgG (Jackson
ImmunoResearch Laboratory) were diluted, respectively, 1:1000
and 1:20000 in 0.05% Tween-20 in TBS. Kaleidoscope Prestained
Molecular Weight Markers (BioRad) were used as size determi-
nants. Some TSP-1 samples were incubated with 0.1 U/mL of the
recombinant protein fusion of b-N-acetyl-hexosaminidase and
maltose binding protein (New England BioLabs) in an equal part
of 50 mM sodium citrate, pH 4.5, for 1 hr at 37uC for removal of
O-linked N-acetyl hexosamine (O-HexNAc) adducts [9] before
immuno-blotting.
Linear Trap Quadrapole Fourier Transform Ion Cyclotron
Resonance (LTQ-FT ICR) MS Analysis
Top-down (LTQ-FT ICR) MS analysis (UW-Madison Human
Proteomics Facility) was performed to look for post-translational
modifications of TSP-1 EGF-like modules. Recombinant E1 of
TSP-1 was dialyzed into 0.1% acetic acid and then diluted in
appropriate buffers to achieve final concentrations of 1% acetic
acid and 30–40% acetonitrile. Collision-induced dissociation
energy was used at q=7. Modified and unmodified peaks were
summed and percent of modification was determined as modified/
total 6100.
Matrix-Assisted Laser Desorption Ionization Time-of-
Flight/Time-of-Flight (MALDI-TOF/TOF) MS
TSP-1 modular constructs were reduced in 10 mM dithiothre-
itol at 56uC for 1 hr, cooled to 22uC, alkylated with 20 mM
iodoacetamide at 22uC for 30 min in the dark, and trypsinized at a
20:1 substrate:protease ratio using sequence grade modified
trypsin (Promega, Cat. #V511A) for 16–20 hours. The Bruker
ULTRAFLEX
TMIII MALDI-TOF (Bruker Daltonics, Inc.) was
used for MS/MS analysis. Tryptic digests were desalted and
concentrated with a C4 zip-tip (see protocol, Michrom Bioscienc-
es) and applied to the MALDI plate with an a-cyano-4-
hydroxycinnammic acid matrix. Laser power was varied to yield
maximum resolution in positive reflectron mode. MALDI-MS
contains soft ionization properties previously shown to work well
with sensitive glycosylation modifications as in this study [9,17].
Results
Identification of EGF-like modules containing an O-b-
GlcNAc consensus sequence
In the course of examining the extent of modification by glucose
(Glc) and xylose (Xyl) on recombinant EGF-like modules of TSP-1
produced in insect High-Five cells [12], we encountered evidence
for an adduct of +203-Da, compatible with O-b-GlcNAc.
Modification by O-b-GlcNAc of intracellular proteins mediated
by cytoplasmic and nuclear O-GlcNAc transferases is well-
described [18,19]. Evidence for lymphocyte cell surface O-b-
GlcNAc modification [20] and the recent description of O-b-
GlcNAc in the extracellular 20
th EGF-like module (E20) of
Drosophila Notch [9] indicate that extracellular proteins, including
those with EGF-like modules, are subject to the modification.
When we compared the sequence of Drosophila Notch that is
modified to the sequence of TSP-1, we found similarities in the
loop between the fifth and sixth cysteines of the first EGF-like
module, i.e., a serine in TSP-1 and a threonine in Notch are
embedded in the sequences PYGSGN and PYGTGQ, respectively
(Figure 2). A BLAST search against the human UniProtKB
database with the sequence between the fifth and sixth cysteines of
the 20
th EGF-like module of Drosophila Notch as bait revealed that
a number of human extracellular matrix and transmembrane
proteins in addition to TSP-1 contained the sequence CXXG(Y/
F)(T/S)GZ2–5C (X typically a Pro or Ala, Z varying from 2–5
residues) between the fifth and sixth cysteines of EGF-like modules
(Figure 2). This list includes the first EGF-like modules of TSP-4
and TSP-5, both group B TSPs. The other group A TSP, TSP-2,
however, has leucine instead of serine as in TSP-1 (Figure 2).
Immuno-blotting for the O-b-GlcNAc modification of
TSP-1
To obtain additional evidence for O-b-GlcNAc modification of
TSP-1, monoclonal antibody CTD110.6, which recognizes
protein-O-b-GlcNAc conjugates [21], was used to immuno-blot
recombinant TSP-1, TSP-1 purified from human platelets, and
recombinant TSP-2. TSP-1 purified from human platelets and
recombinant TSP-1 reacted with the antibody (Figure 3A). In
contrast, recombinant TSP-2, which lacks a modifiable serine or
threonine in the hypothesized recognition sequence (Figure 2), did
Figure 1. Schematic diagram of Group A TSPs modular composition. Group A TSPs, TSP-1 and -2, are trimeric, multi-modular calcium-
binding proteins. The subunit comprises a N-terminal module (N), oligomerization sequence (o), von Willebrand Factor C module (C), three
properdin-like modules (P123), three EGF-like modules (E123), a calcium-binding wire (Ca), and a globular lectin-like C-terminal module (G).
doi:10.1371/journal.pone.0032762.g001
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platelet TSP-1 towards CTD110.6 was diminished after treatment
with b-N-acetyl-hexosaminidase (Figure 3B). Inasmuch as
CTD110.6 recognizes O-b-GlcNAc and antibody reactivity is
sensitive to b-N-acetylhexosaminidase removal of O-HexNAc, i.e.,
O-b-GlcNAc and O-b-N-acetylgalactosamine adducts, these
results indicate that TSP-1, but not TSP-2, is subject to O-b-N-
acetylglucosaminylation. To localize the specific module(s) subject
to modification in TSP-1, recombinant NoC, P123, E123, E12,
E23, E1, E2, E3, and E3CaG constructs (constructs denoted by
the nomenclature noted in the introduction and Figure 1) were
immuno-blotted with CTD110.6. Only constructs containing the
E1 module, which contains the consensus sequence identified
between the fifth and sixth cysteines identified in the BLAST
search, reacted (Figure 3C).
Characterization of modification of the TSP-1 E1 module
To corroborate the immuno-blotting results that mapped the
potential O-b-GlcNAc modification to E1, we utilized top-down
(LTQ-FT ICR) MS modification analysis of the E123, E12, E23,
E1, E2, and E3 modular constructs. E2 contains extra residues in
the loop between the fifth and sixth cysteines, and E3 lacks a
modifiable serine or threonine residue in the loop (Figure 4A).
E123, E12, and E1 contained a +203-Da adduct in addition to the
known Glc (+162 Da) and Xyl (+132 Da) modification of E1
(Figure 4B and data not shown). Species with the +203-Da adduct
accounted for ,85% of E1 (Figure 4B and Table 1). The 942.99-
Da (z=+7) peak, selected because it contains Glc, Xyl, and
HexNAc, was isolated during LTQ-FT ICR MS of the E1
module, and collision-induced dissociation at low energy was
performed to release the carbohydrates while maintaining integrity
of the modular protein. Inspection of the z=+6 ions indicated that
Glc and Xyl were removed separately from HexNAc (Figure 4C),
indicating that the Glc-Xyl and HexNAc modifications occur at
separate sites. LTQ-FT ICR MS analysis of E2 revealed less than
Figure 3. CTD110.6 anti-O-GlcNAc recognition of TSP family of
proteins. (A) Anti-O-GlcNAc immuno-blot (IB) and protein staining of
recombinant TSP-1 (rTSP-1), platelet TSP-1 (pTSP-1), and recombinant
TSP-2 (rTSP-2). Both TSP-1 proteins were positive for CTD110.6
recognition, whereas TSP-2 was negative. Note: the doublet seen with
pTSP-1 is a result of the purification from thrombin-stimulated platelets
as described previously [26]. (B) Loss of anti-O-GlcNAc immuno-
recognition of pTSP-1 after treatment with recombinant b-N-acetyl-
hexosaminidase fusion protein (HEXB, MW=,100-kDa). (C) Protein
staining and anti-O-GlcNAc immuno-blotting of TSP-1 constructs at
equal molar concentrations (nomenclature as described in the
introduction and Figure 1) to narrow down which TSP-1 modules
contain O-b-GlcNAc.
doi:10.1371/journal.pone.0032762.g003
Figure 2. Potential sites of O-b-GlcNAc modification between
the fifth and sixth cysteines of EGF-like modules (E) of human
proteins. The sequence between the fifth and sixth cysteines of the
20
th EGF-like module of Drosophila Notch was used as bait in a BLAST
search of the human UniProtKB database. The number of the module
among the EGF-like modules in a given protein is based on UniProtKB’s
annotation of the human protein sequences. The E1 module of TSP-2 is
also given and discussed in the text.
doi:10.1371/journal.pone.0032762.g002
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exhibited no detectable modification (Figure 4E).
MALDI-TOF/TOF MS sequencing of the TSP-1 E1 module
To learn if the hypothesized recognition sequence is indeed the
site of modification within the E1 module, MALDI-TOF/TOF
MS analysis was performed on tryptic digests of reduced and
alkylated recombinant E1 module. The CGACPPGYSGNGIQC-
TLELVPR tryptic peptide, which contains residues 572–587
(underlined) plus part of tail introduced by the expression strategy,
was detected as +203-Da modified (2610.2-Da), along with a lesser
amount of unmodified peptide (2407.1-Da) (Figure 5A). Isolation
of the 2610.2-Da peak, followed by TOF/TOF sequence analysis
to identify the site of modification localized the modification to
Ser580 confirming O-b-GlcNAc modification (Figure 5B). During
this process, some of the isolated 2610.2-Da peptide peak lost the
modification, yielding one sequence with Ser580 modified and a
second sequence lacking the adduct (Figure 5B).
Discussion
The O-b-GlcNAc post-translational modification is best known
as occurring dynamically on nucleocytoplasmic proteins engaged
in a broad range of biological functions [18,22]. Previous
literature, however, indicates that it is an extracellular modifica-
tion as well [20]. The recent demonstration of O-b-GlcNAc on an
EGF-like module of Drosophila Notch [9] provided additional
evidence that the modification does indeed occur on extracellular
proteins. The present study identifies a site of O-b-GlcNAc
modification in the 1
st EGF-like module of the secreted
extracellular matrix protein TSP-1, which shares features with
the site of O-b-N-acetylglucosaminylation in Notch. A combina-
tion of O-b-GlcNAc specific immuno-blotting, top-down mass
spectrometry, and MALDI-TOF/TOF amino acid sequencing
demonstrated that Ser580 between the fifth and sixth cysteines of
the TSP-1 E1 module contains an O-b-GlcNAc modification.
Intracellular GlcNAc modifications occur through cytoplasmic
and nuclear O-GlcNAc transferases [18]. The identity of O-
GlcNAc transferase(s) that catalyze the modification in secretory
organelles is not known. However, previous literature describes
membrane protein O-b-GlcNAc modification in the Golgi
apparatus [23] as well as at the cell surface [20,24].
E1 is the only EGF-like module of TSP-1 to have a sequence
similar to the sequence for O-b-GlcNAc modification in the Notch
receptor. E2 contains serine and threonine residues but there is an
extra long 23 residue loop between the fifth and sixth cysteines [8].
We found evidencefor minormodificationofE2 by O-b-GlcNAc in
top-down MS analysis but not by immuno-blotting. The sequence
between the fifth and sixth cysteines within the E3 module contains
no serine or threonine residue, and no evidence of modification was
found by top-down MS analysis. The observations suggest that the
short loop between the fifthand sixthcysteinesisthepreferredsite of
O-b-N-acetylglucosaminylation.
E1 of TSP-2, which is homologous to E1 of TSP-1, contains a
leucine, Leu582, at the position of Ser580 of TSP-1 (Figure 2).
Crystallography of a large portion of TSP-2 revealed that Leu582
is in the first strand of a short two-stranded b-sheet that leads into
the Ca
2+-binding site at the interface between E1 and E2 [8]. A
BLAST search found numerous other extracellular proteins that
contain the apparent consensus sequence for O-b-N-acetylgluco-
saminylation between the fifth and sixth cysteines of EGF-like
modules (Figure 2). Some of the EGF-like modules are predicted to
bind calcium; some, like the E1 modules of TSPs [1], are predicted
not to bind calcium; and some, like the EGF-like modules of
Figure 4. Top-down (LTQ-FT ICR) MS modification analysis of
various TSP-1 EGF-like (E) modules. (A) Sequences of the three
TSP-1 EGF-like modules are compared. Only E1 contains the O-GlcNAc
modification consensus sequence. (B) LTQ-FT ICR MS performed on the
TSP-1 E1 module demonstrating modifications in relation to the
unmodified precursor size (6096.74-Da). Known Glc (+162-Da) and Xyl
(+132-Da) modifications were detected, along with the HexNAc (+203-
Da) modification (summed in Table 1). (C) Low energy (q=7) collision-
induced dissociation was then performed on the 6593.93-Da E1 module
peak containing Glc, Xyl, and HexNAc from (B) to see if modifications
were removed separately. Top-down MS analysis was performed on (D)
E2 and (E) E3 modules for comparison.
doi:10.1371/journal.pone.0032762.g004
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common feature beyond the apparent consensus sequence that
distinguishes modules containing the sequence or the context in
which these modules occur. It should be noted the PG(Y/F)(T/
S)G consensus sequence in Figure 2 differs from the (P/V)(P/
A)(V/T)(T/S)(T/S) sequence that characterizes sites of O-b-N-
acetylglucosaminylation of nucleocytoplasmic proteins [22].
E1 plays a pivotal role in the stalk of TSP-1 by determining the
structures of the immediately N-terminal P3 module and
immediately C-terminal E2 module [11,12]. Within a stretch of
83 residues from Trp498 in P3 to Ser580 in E1, all four of the
unusual glycosylations found in TSP-1 are present. O-fucosylation
of properdin-like modules [6,7] and O-glucosylation of EGF-like
modules [25] are important for maturation and structure of
proteins in secretory organelles. We speculate, therefore, that O-b-
N-acetylglucosaminylation may be yet another quality control
mechanism to insure correct processing and targeted to confor-
mationally labile stretches of modules, such as the P3E12 array of
TSP-1, of extracellular matrix or cell surface proteins. In this
context, it is interesting that TSP-2, although lacking O-b-N-
acetylglucosaminylation because of the presence of Leu582 at the
position of Ser580 in TSP-1, is N-glycosylated at Asn584, in the
two-stranded b-sheet [8] and that the homologous sequence in
TSP-5 contains vicinal sites for potential O-b-N-acetylglucosami-
nylation and N-glycosylation (Figure 2).
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